FDA Approves Epidiolex for Severe Forms of Epilepsy

THURSDAY, June 28, 2018 -- The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome for patients age 2 years and older. The rare,...

https://ift.tt/2lJ6xR0